Live Breaking News & Updates on Transposon Therapeutics Inc

Stay updated with breaking news from Transposon therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Transposon Announces Interim Results from a Phase 2 Study of TPN-101 for the Treatment of Progressive Supranuclear Palsy to be Presented at the AD/PD™ 2024 International Conference on Alzheimer's and Parkinson's Diseases

24-Week data show TPN-101 is the first treatment for PSP to reduce NfL levels, a key biomarker of neurodegeneration in tauopathies such as PSP and Alzheimer s disease ....

Andrew Satlin , Rick Orr , Dennis Podlesak , International Conference On Alzheimer , Transposon Therapeutics Inc , International Conference , Chief Medical Officer , Chief Executive Officer , Nucleoside Reverse Transcriptase Inhibitor , Progressive Supranuclear Palsy ,

Frontotemporal Dementia Treatment Drug Market to Showcase Immense Growth During the Study Period (2019–2032) | DelveInsight

New York, USA, Oct. 16, 2023 (GLOBE NEWSWIRE) Frontotemporal Dementia Treatment Drug Market to Showcase Immense Growth During the Study Period (2019–2032) | DelveInsight The overall frontotemporal dementia ....

United States , New York , United Kingdom , Annovis Bio , Eli Lilly , Athira Pharma , Clene Nanomedicine , Inmune Bio , Transposon Therapeutics Inc , Shanghai Hengrui Pharmaceutical Co Ltd , Healthcare Services , Amneal Pharmaceuticals , Sunovion Pharmaceuticals , Anavex Life Sciences , Otsuka Pharmaceutical Co Ltd , Denali Therapeutics Inc , Market Research , Annovis Bio Inc , Curasen Therapeutics Inc , Vanda Pharmaceuticals , Wave Life Sciences , Eisai Inc , Oncolys Biopharma Inc , Passage Bio Inc , Seelos Therapeutics Inc , Ionis Pharmaceuticals Inc ,

Oncolys BioPharma : Non-consolidated Financial Results for the Three Months Ended March 31, 2023

NB: this is a summary translation of the press release original drafted in Japanese for the disclosure required in compliance with the TSE regulations.

. | May 12, 2023 ....

United States , Transposon Therapeutics Inc , Quarterly Financial Results , Reserve Board , Transposon Therapeutics , Financial Position , Financial Results Forecast , Oncolys Biopharma Inc Stock Exchange , Press Release , Se 4588 Jp3202170001 ,

New Clinical Studies In ALS Show Promise

Right now, there is no cure for amyotrophic lateral sclerosis (ALS) and approved therapies only moderately slow progression of the disease. . ....

United States , New York , Sharon Hesterlee , Sabrina Paganoni , Clene Nanomedicine , Muscular Dystrophy Association , Transposon Therapeutics Inc , Stan Appel At Houston Methodist Neurological Institute , Harvard Medical School , Tanabe Pharma Development America Inc , Muscular Dystrophy , Lateral Sclerosis , Tanabe Pharma Development America , Massachusetts General Hospital , Australian Based Phase , Computer Interface , Interface System , Mount Sinai Hospital , Stan Appel , Houston Methodist Neurological Institute , James Berry ,